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10 years ago the very idea that living flesh could be “constructed” by 
engineering principles and combining nonliving materials with cells or growing 
human organs in host animals sounded fantastical to many. Today, the organ shortage 
is an even bigger problem than it was in the past. Scientists are working with 
biotechnology to create genetically engineered organs, reducing the number of donors 
that are so urgently needed on a daily basis. The use of organs from animals has long 
been seen to be a solution to the shortage of donor organs as well. 
The purpose of research is to study the prospects for growing human 
replacement organs. In particular, the achievements of genetic engineering when 
donor organs grow in a lab and the idea of xenotransplantation or implanting human 
stem cells into an early pig embryo.  
David Cooper of the University of Pittsburgh in Pennsylvania and his 
colleagues supported the idea of xenotransplantation, or the transplantation of organs 
and tissues from animal species, such as the pig, to humans [2 , 17]. The advent of 
genetic engineering and cloning techniques offers the prospects of donor organs that 
are protected from destruction by human host. There is work in progress aimed at 
inducing the human recipient to accept an animal organ without the need for 
immunosuppressive drug therapy. The mix of human and animal DNA in modern 
medicine is known as chimera. The name is inspired by a monstrous creature from 
Greek mythology that is depicted as part lion, part goat and part snake. [ 1 ] This idea 
of chimera organs isn't a new concept. In 2010, Japanese scientist Hiromitsu 
Nakauchi, who is now a stem cell biologist at Stanford University, was able to grow a 
rat pancreas inside a mouse. This was a huge breakthrough in chimera research 
because rats and mice are different species.  
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The U.S. National Institutes of Health announced in November that it would 
not support this human-animal research after reviewing a presentation from scientists 
working in the field. The institutes' main concern involves the concept of chimeras 
acquiring a cognitive state. Scientists are essentially asking themselves what happens 
if human stem cells somehow start to create a human brain inside an animal. It's a 
major bioethical question. Although the risk of an animal acquiring human 
consciousness is slim, anything is possible. Moreover, the potential risk have to be 
considered as pig viruses may be transferred from the transplanted organ into the 
human patient, and then spread on other members of community. 
The ultimate goal with the technology is to be able to "regenerate an organ 
that will not be rejected (and can be) grown on demand and transplanted surgically, 
similar to a donor organ." By using the blood or stem cells of either the actual 
patients receiving the transplants or people who are close matches, scientists hope to 
replicate real organs by triggering a type of conduit in which the required cells are 
drawn to the transplanted cells, ultimately replacing them and regenerating on their 
own. Genetically-engineered organs and organ tissue in a laboratory may prove to 
cause more harm than good in the long run, as the long-term side effects of splicing 
man-made tissues and other foreign materials into people's bodies are still largely 
unknown. But the practice is already taking place. Numerous patients around the 
world have already had synthetic blood vessels, windpipes, bladders, and other so-
called "minor" organs and tissues, for instance, implanted into their bodies using a 
technology that involves affixing real human cells onto synthetic scaffolds. [ 3 ] 
Joseph Vacanti, a surgeon-scientist in the field of Pediatric Surgery and 
Transplantation Surgery, realized that the major problem in transplantation was 
insufficient donor organs [ 5 ]. He tried to grow tissue layers, an essential prerequisite 
for constructing entire organs. But the cell layers never grew thicker than a few 
millimeters. Vacanti finally realized that the cells in the interior of each layer were 
not getting enough oxygen and nutrients and could not get rid of their metabolic 
waste. He therefore came up with the idea of using polymer materials with a 
branching porous structure instead of solid polymers, which was a milestone in tissue 
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engineering. His work triggered much enthusiasm about tissue engineering in the 
1990s.  
A number of donors are urgently needed on a daily basis. Growing organs in 
laboratories or inside animals has long been seen to be a solution to the shortage of 
donor organs.  
Conclusion 
The controversial idea of growing human organs in host animals has gotten a 
reality check. Despite recent successes at growing mouse organs in rats, using the 
same trick to grow human organs in larger animals such as pigs is a long way off, 
new research shows. The resulting human-animal chimeras don’t grow well, and few 
human cells survive. 
Genetically-engineered organs and organ tissue in a laboratory may prove to 
cause more harm than good in the long run, as the long-term side effects of splicing 
man-made tissues and other foreign materials into people's bodies are still largely 
unknown. 
Faced with the common problem, Vacanti and Cooper have championed very 
different solutions. Cooper thinks that the best hope of providing more organs lies in 
xenotransplantation—the act of replacing a human organ with an animal one. 
Vacanti, now at Massachusetts General Hospital, has instead been developing 
technology to create genetically tailored organs out of a patient’s own cells, 
abolishing compatibility issues.[ 4]  
REFERENCES 
1. CNN[Електронный ресурс] Organs grown in pigs may help transplant 
patients, scientists say / Режим доступу: 
http://edition.cnn.com/2016/06/09/health/human-organs-chimera-irpt 
2. David K. C., Cooper M.D., Robert P., Lanza M.D.  Xeno: The Promise of 
Transplanting Animal Organs into Humans. Oxford: University Press, 2000 265 p. 
3. Natural News [Електронный ресурс] Synthetic organs organ transplants 
genetically modified humans / Режим доступу: 
http://www.naturalnews.com/040973_synthetic_organs_organ_transplants_geneticall
y_modified_humans.html 
Збірник тез доповідей II міжвузівської науково-практичної конференції «Інноваційнітенденції підготовки 
фахівців в умовах полікультурного та мультилінгвального глобалізованого світу» 
 
  227  
4. The Scientist [Електронный ресурс] Replacement Parts / Режим доступу: 
www.the-scientist.com/?articles.view/articleNo/32409/title/Replacement-Parts 
5. Scientific American How to Grow New Organs 
www.scientificamerican.com/article/how-to-grow-new-organs 
